Lumbar spine bone mineral density (BMD) · patients with osteoporosis
2 findings from 1 review
Quality of life · patients with osteoporosis
1 finding from 1 review
Femoral neck bone mineral density (FN-BMD) · patients with osteoporosis
1 finding from 1 review
New fractures · patients with osteoporosis
It is very uncertain whether chinese herbal medicines plus western medicine changes new fractures (Yigu capsule plus calcium versus placebo plus calcium) compared with western medicine (very low certainty).
4 findings from 1 review
RR 0.06 [0, 1]
1 study · 140 participants
Very low
RR 0.33 [0.01, 8.02]
1 study · 120 participants
Very low
RR 0.44 [0.13, 1.43]
1 study · 155 participants
Very low
Show 1 more finding
Quality of life (Bushenhuoxue therapy plus calcium carbonate tablets and alfacalcidol versus calcium carbonate tablets and alfacalcidol) · patients with osteoporosis
1 finding from 1 review
Death · patients with osteoporosis
1 finding from 1 review
Serious adverse events · patients with osteoporosis
1 finding from 1 review
Death · patients with osteoporosis
1 finding from 1 review
Serious adverse events · patients with osteoporosis
1 finding from 1 review
Lumbar spine bone mineral density (BMD) · patients with osteoporosis
1 finding from 1 review
BMD of ulna (Bushen Yigu soft extract versus placebo) · patients with osteoporosis
1 finding from 1 review
BMD of radius (Bushen Yigu soft extract versus placebo) · patients with osteoporosis
1 finding from 1 review
New fractures · patients with osteoporosis
1 finding from 1 review
Quality of life · patients with osteoporosis
1 finding from 1 review
Acute gout attacks · people with chronic gout
Allopurinol showed no clear difference in acute gout attacks compared with placebo (moderate certainty).
1 finding from 1 review
Pain reduction ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Function ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Tophus regression · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · people with chronic gout
Allopurinol 100‐300 mg daily showed no clear difference in withdrawal due to adverse effects compared with febuxostat 80 mg daily (moderate certainty).
1 finding from 1 review
Serious adverse effects · people with chronic gout
Allopurinol 100‐300 mg daily showed no clear difference in serious adverse effects compared with febuxostat 80 mg daily (moderate certainty).
1 finding from 1 review